News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
《業績》和鉑醫藥(02142.HK)全年純利9,133萬美元增32倍 不派息
和鉑醫藥－Ｂ(02142.HK)公布2025年度業績，收入1.58億美元，按年增加314.6%；毛利1.49億美元，增加344%。錄得純利9,133萬美元，增長31.9倍，每股盈利12美仙。不派末期息。(de/d)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
《業績》和鉑醫藥(02142.HK)全年純利9,133萬美元增32倍 不派息
Close
Recommend
7
Positive
4
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA shares!

和鉑醫藥－Ｂ(02142.HK)  -0.240 (-1.691%)    Short selling $7.17M; Ratio 23.716%   公布2025年度業績，收入1.58億美元，按年增加314.6%；毛利1.49億美元，增加344%。錄得純利9,133萬美元，增長31.9倍，每股盈利12美仙。不派末期息。(de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 12:25.)

Dividend History
Announce DateEventParticular
2025/08/27InterimNo Dividend
2025/03/31FinalNo Dividend
2024/08/28InterimNo Dividend
2024/03/28FinalNo Dividend

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.